HighTower Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,094
Closed -$524K 3844
2025
Q4
$524K Sell
34,094
-9,714
-22% -$107K ﹤0.01% 2579
2025
Q3
$435K Buy
43,808
+19,841
+83% +$207K ﹤0.01% 2724
2025
Q2
$238K Sell
23,967
-4,170
-15% -$43.9K ﹤0.01% 3131
2025
Q1
$365K Sell
28,137
-10,085
-26% -$133K ﹤0.01% 2706
2024
Q4
$488K Sell
38,222
-796
-2% -$9.63K ﹤0.01% 2486
2024
Q3
$441K Sell
39,018
-46,466
-54% -$512K ﹤0.01% 2491
2024
Q2
$963K Sell
85,484
-7,015
-8% -$81.7K ﹤0.01% 1878
2024
Q1
$1.15M Buy
92,499
+3,338
+4% +$43.5K ﹤0.01% 1732
2023
Q4
$1.25M Buy
89,161
+1,323
+2% +$18.4K ﹤0.01% 1730
2023
Q3
$1.3M Sell
87,838
-8,284
-9% -$117K ﹤0.01% 1617
2023
Q2
$1.24M Buy
96,122
+14,333
+18% +$163K ﹤0.01% 1632
2023
Q1
$811K Buy
81,789
+18,241
+29% +$195K ﹤0.01% 1804
2022
Q4
$673K Buy
63,548
+135
+0.2% +$1.57K ﹤0.01% 1921
2022
Q3
$654K Buy
+63,413
New +$826K ﹤0.01% 1854
2022
Q2
Sell
-14,479
Closed -$159K 3317
2022
Q1
$159K Buy
+14,479
New +$176K ﹤0.01% 2895
2014
Q4
Sell
-1,050
Closed -$15K 1604
2014
Q3
$15K Hold
1,050
﹤0.01% 1515
2014
Q2
$17K Hold
1,050
﹤0.01% 1572
2014
Q1
$19K Hold
1,050
﹤0.01% 1494
2013
Q4
$21K Hold
1,050
﹤0.01% 1486
2013
Q3
$12K Hold
1,050
﹤0.01% 1320
2013
Q2
$12K Buy
+1,050
New +$22.1K ﹤0.01% 1276

Other funds holding DVAX

HighTower Advisors's DVAX Position: Q1 2026 in Review

HighTower Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 34,094 shares — an estimated $524K sold.

HighTower Advisors first reported a position in DVAX in Q2 2013 and held it in 21 quarters. The position peaked at $1.3M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • HighTower Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 34,094 Dynavax Technologies shares in Q1 2026, an estimated $524K.
  • HighTower Advisors first reported a position in Dynavax Technologies in Q2 2013 and held it in 21 quarters.
  • HighTower Advisors's Dynavax Technologies position peaked at $1.3M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.